
Create your personal agenda –check the favourite icon
Exhibition Hall
Senior Representative, JAG
What if executing experiments were as seamless as designing it? This session presents a bold new vision for laboratory execution—one that leaves paper behind and transforms protocols into intuitive, digital workflows at unprecedented speed. This includes a landmark collaboration to bring trusted analytical standards into the digital age—making them directly executable as elegant electronic protocols. Designed from the bench up, this approach delivers an exceptional user experience that empowers analysts to work naturally, efficiently, and with confidence. Also get an Agilent design expert’s insights on why UX is a crucial driver for laboratory adoption, productivity, and success, and therefore, is needed to enable the future of laboratory software.
This session explores how the digital lab, designed with integration at its core, enables collaborative innovation across modern R&D environments. Nvaignostics is using real, end-to-end workflows and showcases the advantages of moving toward an ecosystem-based lab model. Attendees will learn what is required to build a future-ready digital lab, how platforms like Sapio facilitate this transformation, and how AI-driven orchestration reduces complexity while preserving governance and traceability. The session concludes with a concise introduction to the ELaiN ecosystem and a forward-looking perspective on what comes next in digital laboratory innovation.
This session will explore how analytical sciences shape the future of laboratories by building aligned, reliable, and efficient systems. We will discuss strategies to enhance data integrity, harmonize methods across laboratories, and foster innovation through advanced technologies. The session will highlight best practices for ensuring quality, consistency, and trust in laboratory results, while also addressing how young professionals can contribute to this evolving vision.
For companies that manufacture and sell laboratory equipment, establishing a strong Laboratory Vision and building aligned, reliable systems through analytical sciences represents a major sales opportunity as well. Such an approach can significantly expand their customer portfolio by enhancing trust and demonstrating added value.
Sustainable laboratory practices are no longer a “nice to have.” Across pharma, biotech, and research institutions, policy frameworks and procurement requirements are rapidly transforming green labs from voluntary initiatives into industry standards. This session explores how regulatory pressure, corporate climate commitments, and supplier tiering programs are accelerating adoption at scale. Drawing on real-world examples from global biopharma and CRO networks, we will examine how transparency, third-party verification, and harmonized purchasing criteria are creating a single sustainability signal across the lab ecosystem - turning ambition into measurable, system-wide impact.
Senior Representative, Chemspeed
Senior Representative Scishield
Senior Representative, Revvity Signals
Senior Representative, CDD
Despite numerous digitalization projects in R&D, gaps between different software solutions often remain. Experiment planning, inventory management, analytical devices, statistical tools, and regional processes frequently stay disconnected. These gaps lead to double work, manual transfers, data errors, and lower engagement among the many colleagues who focus primarily on scientific work rather than IT. Data scientists and lab experts also struggle to combine related data from different sources. Closing these gaps helps unlock the full potential of digitalization by enabling smoother workflows, higher data quality, more efficient use of resources, and stronger adoption of digital ways of working.
Senior Representative, Automata
Data is the key ingredient to unlock greater performance, transparency, and trust in routine laboratories, where efficiency, reliability, and turnaround times are key. This presentation shares the journey of the Data & Analytics Program at Mars, used to manage its network of internal and external Q&FS laboratories. Since 2021, the program has improved performance monitoring, optimization, and governance within a complex operational ecosystem. Alongside outcomes, the session shares challenges encountered, from data harmonization to change management, and lessons learned. Attendees will gain practical insights into applying data and analytics to improve decision-making, transparency, and customer satisfaction in routine laboratory environments.
A global ELN rollout is more than an IT project—it's a strategic enabler for digital transformation. This talk outlines how to align goals across regions, simplify processes, and connect teams through a unified digital platform. We highlight key success factors and also discuss common risks and pitfalls. Leaders will gain a concise roadmap for turning a global ELN into a catalyst for efficiency, data quality, and smarter decision‑making across the organization.
The CO₂ Calculator is a groundbreaking initiative developed in EPFL to enable research labs to measure and reduce their environmental impact and will be deployed in summer 2026. It provides a rigorous yet practical way to assessthe carbon footprint ofenergy use, travel, equipment, and procurement.
This toolwill be used to cover the first stage of a three-step sustainability journey currentlyimplementedat the pilot scale inEPFLfaculties:
Exhibition Hall
Senior Representative, ZONTAL
Senior Representative, Zifo
This session will explore how a consulting-driven approach can support organizations in developing a future-ready blueprint for digitalization in the chemical industry—one that integrates strategic alignment, workforce capability, and supply chain excellence. The presentation will highlight how agentic ways of working are expected to empower consultants, planners, and transformation teams to collaborate effectively with artificial intelligence, enabling meaningful improvements in supply chain operations. It will demonstrate how developing a shared understanding of goals and processes and investing in targeted upskilling can enhance human capabilities for AI-augmented decision-making. The session will also emphasize the importance of embedding agentic behaviours and work patterns into daily operations, rather than treating AI as a stand-alone technology deployment. Attendees will gain a practical, people-centric roadmap for scaling digital transformation across complex chemical supply chains—ensuring that technological advancements translate into sustainable, enterprise-wide impact.
IDMP is already being adopted across the pharmaceutical industry as acore enablerof digital transformation - not just a regulatory requirement. By providing a harmonized, machine‑readable structure for medicinal product data, IDMP unlocks true interoperability across regulatory, safety, manufacturing, and supply‑chain systems, enabling consistent data exchange and lifecycle continuity. The EMA notes that IDMP ensures reliable, unambiguous communication of product information, forming the backbone of digital operations.
Industry benchmarks confirm that 89% of companies now consider IDMP central to their digitalization strategy, driving AI readiness, automation, and mature data governance.
This session explores how IDMP transforms compliance into scalable digital capability.
How can research laboratories shift from a linear “buy-use-discard” approach to a more circular economy model for their devices? Transitioning from a linear to a circular model requires rethinking how these assets are managed throughout their lifecycle. This talk integrates laboratory management, quality considerations, and sustainability initiatives to demonstrate how the Value Hill framework can uncover opportunities for value retention and optimization. Supportive emerging solutions will be highlighted, including My Green Lab’s and I2SL’s Freezer Challenge. Evotec’s active participation demonstrates how improved practices related to ultra-low temperature (ULT) freezers can reduce environmental impact while safeguarding performance and compliance.
Senior Representative, Benchling
Enterprise AI is failing at scale: despite massive investment, only a small fraction of organizations generate real value. The core problem is context. While generative AI can reason fluently, it lacks the semantic grounding required to operate reliably in complex enterprise environments. Knowledge graphs are often treated as databases rather than executable context, leading to brittle systems and confident hallucinations.
In pharma operations, where regulatory, supply chain, and safety constraints are non-negotiable, semantic precision is essential. AstraZeneca’s Operations Knowledge Fabric shifts from data lakes to semantic-first data products, living ontologies, and graph-native infrastructure. By embedding meaning directly into data, we enable faster AI deployment, higher-quality decisions, and a foundation for autonomous, domain-aware systems.
The vision of the “dark lab” is to create a laboratory with minimal human intervention. Until now, this goal has required significant resources, making it largely inaccessible to smaller laboratories and universities. However, recent advances in digitalization and automation make laboratory automation more accessible. Key enablers include cost-effective collaborative robots, drag-and-drop low-code software, and the growing adoption of open standards for direct device integration. This presentation compares laboratory automation approaches that require no deep programming or engineering knowledge, using practical examples to show how democratized automation can enhance efficiency, accessibility, and innovation in research, bringing light to the “dark lab.
Exhibition Hall
Senior Representative, Siemens
How do you move from LLM experiments to business impact in a lab. I will share our roadmap from first internal chatbots to knowledge bases and agent style workflows that support scientists in daily HTE operations. The focus is on what changed in practice and what moved the numbers: faster cycle times, improved data quality and traceability, and quicker troubleshooting. The talk will explore how emerging AI tools are reshaping the way we think about automation, collaboration, and decision making in the lab—highlighting opportunities, lessons learned, and what’s next on the horizon for data‑driven experimentations. Our journey is still at an early stage, and I will reflect on how the latest extended capabilities of our HTE laboratory in Frankfurt—ranging from new automation modules to integrated data pipelines.
Senior Representative, Gingko Bioworks
Senior Representative, SciY
New Approach Methodologies (NAMs) like iPSC-derived heart tissues promise to replace animal models in cardiovascular drug screening, but require standardization for regulatory acceptance. autoOrgan.3R is an automated test platform for high-throughput 2D (384-well monolayers) and 3D (EHM in myrPlates) tissue cultures.
We integrate robotics, SiLA2 standardization, and AI analysis (SarcAsM, pole-tracking) for pilot screens, efficacy (contractility), and safety (arrhythmia) validation. This ensures batch-to-batch consistency, low contamination, and precise functional readouts, aligning with 3R goals by reducing Germany's 130,000 annual CV animal tests
I will share practical insights from enterprise cybersecurity initiatives that laboratories can adopt to strengthen data protection and operational resilience. The session will cover conducting risk assessments to identify and protect the laboratory’s crown jewels, implementing third-party and supplier security to safeguard collaborations, and embedding secure-by-design principles into projects from the outset. Attendees will learn how to turn these insights into actionable operational decisions, protect sensitive research data, and foster innovation without compromising compliance or continuity.
Exhibition Hall
Create your personal agenda –check the favourite icon
Senior Representative, Siemens
Exhibition Hall
Senior Representative, Wega
Interoperability is a key enabler of laboratory digitalization, automation, and AI-driven analyses. This presentation outlines the stages of interoperability based on international definitions and examines how connectivity, data management standards, and digital transformation enable seamless system integration. Particular emphasis is placed on the interplay between syntactic and semantic interoperability in automated laboratories to ensure consistent data interpretation across workflows involving heterogeneous devices and systems. Through practical examples, we demonstrate how enhanced interoperability supports efficient data exchange and collaboration, fostering innovation in laboratory environments. Attendees will gain insights into the strategic relevance of interoperability for automation and AI-driven pharmaceutical R&D.
Senior Representative, Siemens
Synthos collaborates with global tire manufacturers to pioneer sustainable synthetic rubber solutions. Our functionalized SSBR grades enhance energy efficiency by reducing rolling resistance and extend tire life through improved abrasion resistance, supporting compliance with upcoming Euro 7 tire abrasion limits. In the R&D labs we implemented a tailor-made LIMS and ELN system covering synthesis, polymerization, and performance evaluation, integrated with a chemical database for streamlined data access. This talk highlights the challenges faced, the improvement project undertaken, and how efficiency gains in R&D accelerate innovation for environmentally responsible mobility.
Exhibition Hall
Staige AI cameras empower laboratories to transition from manual oversight to intelligent automation. These systems continuously capture and analyze visual data, supporting applications such as equipment monitoring, sample tracking, safety compliance, and process optimization as well as others. The integration of AI‑vision accelerates decision‑making, enhances reproducibility, and enables laboratories to operate with unprecedented precision and agility.
For conference production and speaking opportunites:
Für die Produktion von Konferenzen und die Möglichkeit, Vorträge zu halten:
For sponsorship and exhibition opportunities: